129 related articles for article (PubMed ID: 31029713)
1. Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study.
Porta L; Lee MG; Hsu WT; Hsu TC; Tsai TY; Lee CC
Resuscitation; 2019 Jun; 139():262-268. PubMed ID: 31029713
[TBL] [Abstract][Full Text] [Related]
2. Oral Fluoroquinolone and the Risk of Aortic Dissection.
Lee CC; Lee MG; Hsieh R; Porta L; Lee WC; Lee SH; Chang SS
J Am Coll Cardiol; 2018 Sep; 72(12):1369-1378. PubMed ID: 30213330
[TBL] [Abstract][Full Text] [Related]
3. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
Inghammar M; Svanström H; Melbye M; Pasternak B; Hviid A
BMJ; 2016 Feb; 352():i843. PubMed ID: 26920666
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolones and the risk of serious arrhythmia: a population-based study.
Lapi F; Wilchesky M; Kezouh A; Benisty JI; Ernst P; Suissa S
Clin Infect Dis; 2012 Dec; 55(11):1457-65. PubMed ID: 22865870
[TBL] [Abstract][Full Text] [Related]
5. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.
Zambon A; Polo Friz H; Contiero P; Corrao G
Drug Saf; 2009; 32(2):159-67. PubMed ID: 19236122
[TBL] [Abstract][Full Text] [Related]
6. Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.
Cornett E; Novitch MB; Kaye AD; Pann CA; Bangalore HS; Allred G; Bral M; Jhita PK; Kaye AM
Postgrad Med; 2017 Sep; 129(7):715-724. PubMed ID: 28770640
[TBL] [Abstract][Full Text] [Related]
7. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
[TBL] [Abstract][Full Text] [Related]
8. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
[TBL] [Abstract][Full Text] [Related]
9. Exploring the effect of transient exposure on the risk of acute events by means of time-window designs: an application to fluoroquinolone antibacterials and arrhythmia.
Corrao G; Botteri E; Bertù L; Zambon A; Favilli S
Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):31-7. PubMed ID: 15954079
[TBL] [Abstract][Full Text] [Related]
10. Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
Cho Y; Park HS
BMJ Open; 2018 Sep; 8(9):e020974. PubMed ID: 30269062
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis.
Liu X; Ma J; Huang L; Zhu W; Yuan P; Wan R; Hong K
Medicine (Baltimore); 2017 Nov; 96(44):e8273. PubMed ID: 29095256
[TBL] [Abstract][Full Text] [Related]
12. Association Between Oral Fluoroquinolone Use and Retinal Detachment.
Raguideau F; Lemaitre M; Dray-Spira R; Zureik M
JAMA Ophthalmol; 2016 Apr; 134(4):415-21. PubMed ID: 26967005
[TBL] [Abstract][Full Text] [Related]
13. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
Chen HL; Hsiao FY
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):841-8. PubMed ID: 26098410
[TBL] [Abstract][Full Text] [Related]
14. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
[TBL] [Abstract][Full Text] [Related]
15. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
[TBL] [Abstract][Full Text] [Related]
16. Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities.
Polgreen LA; Riedle BN; Cavanaugh JE; Girotra S; London B; Schroeder MC; Polgreen PM
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680825
[TBL] [Abstract][Full Text] [Related]
17. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolones and the risk of serious arrhythmia.
Trezza C; Khadem TM; Snyder C; Brown J
Clin Infect Dis; 2013 May; 56(9):1356. PubMed ID: 23362299
[No Abstract] [Full Text] [Related]
19. The risk profile of rhegmatogenous retinal detachment before and after using a fluoroquinolone: a 12 year nationwide self-controlled case series study.
Shin JY; Jeong S; Jeon HL; Byun S; Park KH; Jeong HE; Park SJ
J Antimicrob Chemother; 2018 Dec; 73(12):3442-3453. PubMed ID: 30165476
[TBL] [Abstract][Full Text] [Related]
20. BET 1: What is the incidence of cardiac arrhythmia in adult patients with acute infection prescribed fluoroquinolones?
Chan K; Fitzpatrick J
Emerg Med J; 2019 Oct; 36(10):635-638. PubMed ID: 31551305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
